Welcome Guest
Home > Clinical Lung Cancer > Volume 8 | Supplement 1

Table of Contents

Volume 8 | Supplement 1

Publication Date: December 2006
  • Abstract
  • No Access
  • Pay-Per View
  • Full Text
  • Add to Cart


Introduction

S6		 Therapeutic Ratio of Targeted Therapies in Non–Small-Cell Lung Cancer
David R. Gandara
Contributions

S7-S14		 Rash as a Surrogate Marker for Efficacy of Epidermal Growth Factor Receptor Inhibitors in Lung Cancer
Roman Perez-Soler

S15-S22		 Managing Dermatologic Toxicities of Epidermal Growth Factor Receptor Inhibitors
Lillian S. Chou, Jody Garey, Karen Oishi, Edward Kim

S23-S30		 Toxicities of Antiangiogenic Therapy in Non–Small-Cell Lung Cancer
Roy S. Herbst

S31-S35		 Interstitial Lung Disease Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Non–Small-Cell Lung Carcinoma
Ken Y. Yoneda, Kimberly A. Hardin, David R. Gandara, David K. Shelton

S36-S42		 Non-Rash Skin Toxicities Associated with Novel Targeted Therapies
Mario E. Lacouture, Scott A. Boerner, Patricia M. LoRusso
  1. https://www.ceteresopolitano.org/
  2. https://www.crossingstoronto.com/
  3. https://www.jediism.org/
  4. https://www.badenumc.org/
  5. https://www.johnsevierchapter.org/
  6. https://www.trinitychapelmn.org/
  7. https://www.photogearnews.com/
  8. https://www.alz-nova.org/
  9. https://www.cigjournals.com/
  10. https://summa-edu.com/
  11. https://cpawilmingtonnc.org/
  12. https://bimometals.com/
  13. https://sosenvironmental.com/
  14. https://thefriary.org/
  15. https://post5theatre.org/
  1. KELUARAN SGP
  2. TOGEL